Lacticaseibacillus paracasei sh2020 induced antitumor immunity and synergized with anti-programmed cell death 1 to reduce tumor burden in mice
出版年份 2022 全文链接
标题
Lacticaseibacillus paracasei sh2020 induced antitumor immunity and synergized with anti-programmed cell death 1 to reduce tumor burden in mice
作者
关键词
-
出版物
Gut Microbes
Volume 14, Issue 1, Pages -
出版商
Informa UK Limited
发表日期
2022-03-09
DOI
10.1080/19490976.2022.2046246
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Lactobacillus rhamnosus GG induces cGAS/STING- dependent type I interferon and improves response to immune checkpoint blockade
- (2021) Wei Si et al. GUT
- Impact of intestinal dysbiosis-related drugs on the efficacy of immune checkpoint inhibitors in clinical practice
- (2020) E. Pérez-Ruiz et al. Clinical & Translational Oncology
- Intratumoral accumulation of gut microbiota facilitates CD47-based immunotherapy via STING signaling
- (2020) Yaoyao Shi et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Gut Bacteria Composition Drives Primary Resistance to Cancer Immunotherapy in Renal Cell Carcinoma Patients
- (2020) Lisa Derosa et al. EUROPEAN UROLOGY
- Microbiome-derived inosine modulates response to checkpoint inhibitor immunotherapy
- (2020) Lukas F. Mager et al. SCIENCE
- A Microbiota-Derived Metabolite Augments Cancer Immunotherapy Responses in Mice
- (2020) Emma Allen-Vercoe et al. CANCER CELL
- Stool Microbiome Profiling of Patients with Metastatic Renal Cell Carcinoma Receiving Anti–PD-1 Immune Checkpoint Inhibitors
- (2020) Nicholas J. Salgia et al. EUROPEAN UROLOGY
- Immunotherapy in colorectal cancer: rationale, challenges and potential
- (2019) Karuna Ganesh et al. Nature Reviews Gastroenterology & Hepatology
- Intratumoral Activity of the CXCR3 Chemokine System Is Required for the Efficacy of Anti-PD-1 Therapy
- (2019) Melvyn T. Chow et al. IMMUNITY
- Exploring the emerging role of the microbiome in cancer immunotherapy
- (2019) Jessica Fessler et al. Journal for ImmunoTherapy of Cancer
- Probiotics Ameliorate Colon Epithelial Injury Induced by Ambient Ultrafine Particles Exposure
- (2019) Xiaobo Li et al. Advanced Science
- Regulation and Function of the PD-L1 Checkpoint
- (2018) Chong Sun et al. IMMUNITY
- Tumor Cell-Intrinsic Factors Underlie Heterogeneity of Immune Cell Infiltration and Response to Immunotherapy
- (2018) Jinyang Li et al. IMMUNITY
- The commensal microbiome is associated with anti–PD-1 efficacy in metastatic melanoma patients
- (2018) Vyara Matson et al. SCIENCE
- Balances: a New Perspective for Microbiome Analysis
- (2018) J. Rivera-Pinto et al. mSystems
- Successful Anti-PD-1 Cancer Immunotherapy Requires T Cell-Dendritic Cell Crosstalk Involving the Cytokines IFN-γ and IL-12
- (2018) Christopher S. Garris et al. IMMUNITY
- Modulating the Tumor Microenvironment via Oncolytic Viruses and CSF-1R Inhibition Synergistically Enhances Anti-PD-1 Immunotherapy
- (2018) Gang Shi et al. MOLECULAR THERAPY
- Fecal microbiota transplantation for refractory immune checkpoint inhibitor-associated colitis
- (2018) Yinghong Wang et al. NATURE MEDICINE
- Pan-tumor genomic biomarkers for PD-1 checkpoint blockade–based immunotherapy
- (2018) Razvan Cristescu et al. SCIENCE
- Therapeutic faecal microbiota transplantation controls intestinal inflammation through IL10 secretion by immune cells
- (2018) Claudia Burrello et al. Nature Communications
- Gavage of Fecal Samples From Patients With Colorectal Cancer Promotes Intestinal Carcinogenesis in Germ-Free and Conventional Mice
- (2017) Sunny H. Wong et al. GASTROENTEROLOGY
- Potential role of intratumor bacteria in mediating tumor resistance to the chemotherapeutic drug gemcitabine
- (2017) Leore T. Geller et al. SCIENCE
- Gut microbiome influences efficacy of PD-1–based immunotherapy against epithelial tumors
- (2017) Bertrand Routy et al. SCIENCE
- Interleukin-21 combined with PD-1 or CTLA-4 blockade enhances antitumor immunity in mouse tumor models
- (2017) Katherine E. Lewis et al. OncoImmunology
- Enterotypes in the landscape of gut microbial community composition
- (2017) Paul I. Costea et al. Nature Microbiology
- Development of immuno-oncology drugs — from CTLA4 to PD1 to the next generations
- (2016) Axel Hoos NATURE REVIEWS DRUG DISCOVERY
- Probiotics modulated gut microbiota suppresses hepatocellular carcinoma growth in mice
- (2016) Jun Li et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- PD-L1 (B7-H1) and PD-1 pathway blockade for cancer therapy: Mechanisms, response biomarkers, and combinations
- (2016) Weiping Zou et al. Science Translational Medicine
- Robust enumeration of cell subsets from tissue expression profiles
- (2015) Aaron M Newman et al. NATURE METHODS
- The future of immune checkpoint therapy
- (2015) P. Sharma et al. SCIENCE
- Fecal Microbiota Characteristics of Patients with Colorectal Adenoma Detected by Screening: A Population-based Study
- (2015) James J. Goedert et al. EBioMedicine
- Cancer cell–autonomous contribution of type I interferon signaling to the efficacy of chemotherapy
- (2014) Antonella Sistigu et al. NATURE MEDICINE
- QUAST: quality assessment tool for genome assemblies
- (2013) Alexey Gurevich et al. BIOINFORMATICS
- UPARSE: highly accurate OTU sequences from microbial amplicon reads
- (2013) Robert C Edgar NATURE METHODS
- The gut microbiota — masters of host development and physiology
- (2013) Felix Sommer et al. NATURE REVIEWS MICROBIOLOGY
- Ribosomal Database Project: data and tools for high throughput rRNA analysis
- (2013) James R. Cole et al. NUCLEIC ACIDS RESEARCH
- Lactobacillus brantae sp. nov., isolated from faeces of Canada geese (Branta canadensis)
- (2011) D. V. Volokhov et al. INTERNATIONAL JOURNAL OF SYSTEMATIC AND EVOLUTIONARY MICROBIOLOGY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started